Where do Indians spend the most from their own pocket on healthcare?
Kerala recorded the highest per capita Out-of-Pocket Expenditure (OOPE) at ₹7,889 per person annually, while Bihar reported the lowest at ₹984. India’s average OOPE stood at ₹2,600 per person in 2021–22.
Source: National Health Accounts (State-wise OOPE), 2021–22.
Indians pay more out of their own pockets for healthcare than almost any large economy in the world. The national average out-of-pocket expenditure (OOPE) stood at ₹2,600 per person in 2021-22, but this hides enormous state-wise, disease-wise, and income-wise variation — from Bihar’s ₹984 to Kerala’s ₹7,889 per capita. One bad diagnosis — cancer, a heart attack, a road accident — can wipe out years of savings in a single hospital admission. This is exactly why insurance stopped being optional a long time ago, and why 2026 is the year most Indian households can no longer afford to go without it.
This report walks through the official state-wise data (sourced from figures tabled in the Rajya Sabha and National Health Accounts estimates), disease-specific treatment costs, and the psychology of insurance mistrust — and answers, honestly, why people still hesitate to buy a policy despite the numbers screaming otherwise.
What Does “Out-of-Pocket Expenditure” Actually Mean?
Before the statistics, the definition matters — because this term gets thrown around loosely in news headlines.
Out-of-Pocket Expenditure (OOPE) is the direct payment a household makes to a hospital, clinic, pharmacy, or diagnostic lab at the time of receiving care — money that is not reimbursed by insurance, an employer, or a government scheme. It covers consultation fees, medicines, diagnostic tests, hospital room charges, surgery costs, and consumables like syringes or implants.
It is different from a few other terms that often get confused with it:
- Total Health Expenditure (THE) is the sum of everything spent on healthcare in the country — government spending, insurance payouts, OOPE, and external aid combined.
- Government Health Expenditure (GHE) is what the central and state governments spend on public health infrastructure and schemes.
- Catastrophic Health Expenditure (CHE) is a specific, more alarming idea: when a household’s health spending crosses a threshold (commonly 10% of total consumption expenditure) that pushes it toward financial distress — selling assets, taking loans, or falling into poverty.
OOPE is the everyday burden. Catastrophic expenditure is what happens when that burden becomes a crisis. Both matter, and in India, both are still uncomfortably high.
The National Picture: Progress, But From a Very Low Base
India’s OOPE story over the last decade is genuinely one of improvement — just not enough of it. According to National Health Accounts estimates, OOPE as a share of Total Health Expenditure fell from roughly 64% in 2013-14 to around 39-43% by 2021-22, as government health spending rose. That is a real and meaningful shift, driven largely by schemes like Ayushman Bharat (PM-JAY) and increased state health budgets.
But context matters. Even at its improved level, India’s OOPE share remains far above the World Health Organization’s recommended threshold of 15-20% for a health system to be considered financially protective, and well above what most middle-income and high-income countries report. Households in India still fund a much larger share of their medical bills directly than households in Thailand, China, or Brazil — countries India is often benchmarked against.
In absolute terms, official figures tabled in the Rajya Sabha put per capita OOPE at ₹2,600 nationally in 2021-22, up steadily from ₹2,097 in 2017-18. That’s not a typo-worthy improvement — it’s a household expense that has grown every single year, even as its share of total health spending declined. Health is simply getting more expensive faster than incomes are rising, and government spending — while growing — hasn’t yet closed the gap.
State-by-State: Where the Burden Really Falls
This is where the picture gets far more interesting than a single national average, and it’s the section that most people searching for this topic actually want answered.
Based on official per capita OOPE figures for 2021-22:
The highest-spending states:
- Kerala – ₹7,889
- West Bengal – ₹4,010
- Himachal Pradesh – ₹3,844
- Andhra Pradesh – ₹3,834
- Punjab – ₹3,668
The lowest-spending states:
- Bihar – ₹984
- Assam – ₹1,180
- Chhattisgarh – ₹1,419
- Jammu & Kashmir – ₹1,581
- Uttarakhand – ₹1,560
At first glance, this looks like good news for Bihar and bad news for Kerala. It is almost the opposite.
The Kerala Paradox
Kerala has India’s highest literacy rate, one of its highest life expectancies, and consistently ranks at or near the top of NITI Aayog’s health index. Yet it also has, by a wide margin, the highest per capita out-of-pocket healthcare spending in the country — nearly three times the national average.
Why? Because Kerala’s population is ageing faster than most other states, its residents rely heavily on private hospitals even when public infrastructure is available, and higher awareness means people seek treatment more often and more proactively — including for non-communicable diseases (NCDs) like diabetes and cardiovascular conditions that require ongoing, expensive management. Kerala isn’t spending more because its healthcare system is failing; it’s spending more because its people are using more healthcare, mostly through the private sector.
The Bihar Trap
Bihar’s low OOPE number tells the opposite story. It isn’t a sign of an efficient, low-cost health system — it’s a sign of a population that simply isn’t accessing care at the same rate. Distance to tertiary hospitals, distrust of formal healthcare, and affordability constraints mean many households delay treatment, rely on unqualified local providers, or skip care altogether. Low spending, in this case, often correlates with under-treatment rather than efficiency.
The takeaway for a national reader: Your state’s average tells you almost nothing about your personal risk. What actually determines your bill is which hospital you walk into and which disease you’re treated for — and that’s a decision insurance, not geography, should be protecting you from.
Disease-Wise: Where the Real Financial Shock Comes From
State averages are useful for policy discussions. They are almost useless for a family staring down an actual diagnosis. This is where disease-specific data matters far more.
Heart Disease and Bypass Surgery
Coronary Artery Bypass Grafting (CABG) — commonly known as bypass surgery — costs anywhere from ₹1.5 lakh to ₹5.5 lakh in private hospitals across India, with significant city-wise variation:
- Mumbai and Bangalore sit at the premium end, around ₹2.2L–₹5.5L
- Delhi and Pune fall in the ₹2L–₹4.5L range
- Ahmedabad and Chennai are comparatively lower, around ₹1.5L–₹4L
- Kolkata and Hyderabad sit in the ₹1.7L–₹4.5L band
Even the lower end of this range — ₹1.5 lakh — is more than many Indian households’ entire annual income. And this is for a single procedure, before accounting for pre-surgery diagnostics, post-operative medication, cardiac rehabilitation, and follow-up consultations that continue for years.
A ₹10 lakh health insurance cover — often considered generous — can be entirely consumed by a single bypass surgery at a metro hospital. That single data point should reframe how anyone thinks about “how much cover is enough.”
Diabetes: The Slow-Burning Financial Drain
India’s diabetes incidence data reveals a quieter but arguably more dangerous crisis. The national average incidence rate stands at 264 per 100,000 population, but several states are dramatically above that:
- Tamil Nadu – 392 (highest in the country)
- Karnataka – 307
- Goa – 314
- Manipur – 295
- Kerala – 285
Unlike a surgery, diabetes doesn’t bankrupt a family in one bill — it does it gradually, through decades of medication, monitoring, and eventual complications like foot ulcers, kidney damage, or cardiovascular disease. Standard health insurance products have historically excluded pre-existing conditions like diabetes or imposed long waiting periods before covering related complications — which is precisely the kind of “fine print” experience that has made many Indians distrustful of insurers in the first place. It’s also why choosing a policy that clearly covers NCD management, and understanding the waiting period before you buy, matters more than the headline sum insured.
The Most Expensive Diagnoses in India
Some conditions are financially catastrophic almost by definition. For 2024-25, average private treatment costs include:
- Blood cancer (bone marrow transplant): ₹25L–₹35L — this alone exceeds even a ₹10 lakh cover by 200%+
- Advanced lung cancer: ₹10L–₹20L — capable of exhausting a ₹10 lakh policy on its own
- Kidney transplant: ₹6L–₹12L
- Bypass surgery (CABG): ₹5L–₹10L — can consume an entire ₹10 lakh cover
- Stroke treatment: ₹2L–₹6L
- Angioplasty: ₹2.5L–₹5L
- Chemotherapy: ₹20,000–₹1.5 lakh per cycle, with most cancer treatments requiring 6-12+ cycles
- Hemodialysis: ₹18,000–₹48,000 per month, recurring for years in chronic kidney disease
Look closely at that chemotherapy and dialysis data. These aren’t one-time bills. They’re recurring monthly or cyclical expenses that keep drawing from a family’s account long after the initial diagnosis. A ₹10 lakh sum insured that looks adequate on paper for a “one-time event” can be depleted within a single year of ongoing cancer or kidney treatment.
This is precisely the gap between what people think insurance protects them from (a single hospital bill) and what actually threatens their finances (a sustained, multi-year treatment course).
Why the Public vs. Private Gap Makes Insurance Non-Negotiable
One of the most consistent findings across every available dataset — government surveys, National Health Accounts, and independent studies — is the enormous cost gap between public and private healthcare in India.
Private hospital bills for the same broad category of hospitalization are typically 5 to 8 times higher than public hospital bills. Public sector OOPE tends to represent a much smaller share of total treatment cost (government subsidy covers the rest), whereas in private hospitals, the patient bears the overwhelming majority of the cost directly — often over 80% of the total bill.
Here’s the uncomfortable truth this creates: most Indians, when given the choice, prefer private hospitals — for perceived quality, shorter wait times, and better infrastructure. But preferring private care while remaining uninsured is financially incoherent. It means choosing the more expensive option while removing your only mechanism to pay for it without debt or asset sales.
“But Insurance Claims Get Rejected”
If you’ve read this far, you’re probably not someone who needs convincing that healthcare is expensive. You need convincing that insurance actually works when the bill arrives — because somewhere on the internet, you’ve read a claim-rejection horror story, or maybe experienced one yourself.
This skepticism is valid, and it deserves a straight answer rather than a marketing dismissal.
Claims usually get rejected for a small number of recurring, avoidable reasons:
- Non-disclosure of pre-existing conditions. If a policyholder doesn’t disclose a known condition (like diabetes or hypertension) at the time of buying the policy, and it later relates to a claim, insurers can reject it on grounds of misrepresentation. This is the single largest cause of claim disputes in India.
- Buying during a waiting period and expecting immediate coverage. Most policies have a waiting period — commonly 2 to 4 years — for pre-existing diseases, and a much shorter one (typically 30 days) for illnesses in general. A claim filed inside that window is often, correctly, denied.
- Choosing the cheapest policy without reading sub-limits. Some low-premium policies cap room rent, cap specific procedures, or apply co-payment clauses that leave the policyholder paying a percentage of the bill regardless of the sum insured. This isn’t “the insurer cheating you” — it’s a policy structure the buyer didn’t fully understand at purchase.
- Network hospital confusion. Cashless treatment is only guaranteed at hospitals empanelled with your insurer or third-party administrator (TPA). Going to a non-network hospital doesn’t mean no reimbursement — it means the process shifts from cashless to reimbursement, which some patients mistake for rejection.
None of these four reasons are an argument against buying insurance. They’re an argument for buying it carefully — disclosing your medical history honestly, reading the waiting period and sub-limit clauses, and choosing a sum insured that reflects actual treatment costs (see the cancer and dialysis numbers above) rather than the cheapest premium available.
The data above should reframe the real risk calculation: the danger of a bad insurance experience is a bureaucratic hassle. The danger of no insurance is a ₹25 lakh bone marrow transplant bill, in full, from your own savings.
How Indians Currently Pay for Healthcare — and Why It’s Unsustainable
When a health emergency hits an uninsured or under-insured household, the money has to come from somewhere. Across available survey data, the pattern is remarkably consistent:
- The majority of households draw first from savings and current income
- A significant share turn to borrowing — from banks, moneylenders, or relatives
- Gold loans have surged in recent years, frequently linked to medical emergencies
- Asset sales become common as health shocks deepen, particularly for cancer and chronic disease treatment
- Medical crowdfunding has grown into a meaningful (and telling) channel for financing treatment — a sign that formal financial protection isn’t reaching enough people
Every one of these is a coping mechanism, not a solution. Selling land or jewellery to pay for a bypass surgery doesn’t just cost money in the moment — it removes a family’s long-term financial cushion, often for a generation. This is the actual, lived version of “catastrophic health expenditure” that the statistics describe abstractly.
Why 2026 Specifically Changes the Calculation
Three trends are converging right now that make delaying an insurance decision riskier than it was even five years ago:
1. Medical inflation is outpacing general inflation by roughly 2-2.5x. While general consumer inflation in India has hovered in the mid-single digits, healthcare cost inflation has consistently run at 12-14% annually. A treatment that cost ₹1 lakh in 2014 realistically costs ₹3-4 lakh today. Sums insured that felt adequate a decade ago are now dangerously undersized.
2. NCD burden is rising, not falling. Diabetes, hypertension, and cardiovascular disease incidence continues climbing across states — including in states that historically had lower burdens. These aren’t one-time emergencies; they require years of managed, recurring healthcare spending that a family’s monthly budget alone cannot absorb.
3. Insurance penetration remains a genuine gap, not a saturated market. Despite growth in Ayushman Bharat and state schemes, a large share of India’s population — particularly the “missing middle” who are neither poor enough for government schemes nor affluent enough for comprehensive private cover — remains inadequately protected. If you’re reading this and unsure which category you fall into, that uncertainty itself is the signal to act.
Frequently Asked Questions
What is a good out-of-pocket expenditure percentage for a healthy financial system? The WHO benchmark for a financially protective health system is OOPE at 15-20% or lower of total health expenditure. India’s current figure, even after a decade of improvement, remains roughly double to nearly triple that benchmark.
Which Indian state has the highest healthcare out-of-pocket spending? Kerala, at approximately ₹7,889 per capita annually (2021-22 data), followed by West Bengal and Himachal Pradesh.
Which state has the lowest out-of-pocket healthcare spending? Bihar, at approximately ₹984 per capita — though this reflects lower healthcare access and utilization rather than lower treatment costs.
How much does a heart bypass surgery cost in India? Private hospitals typically charge between ₹1.5 lakh and ₹5.5 lakh depending on the city, with metro hospitals in Mumbai and Bangalore at the higher end.
Can a ₹10 lakh health insurance policy cover cancer treatment? It depends heavily on the type and stage of cancer. Blood cancer treatments involving bone marrow transplants (₹25L-₹35L) and advanced lung cancer (₹10L-₹20L) can exceed or fully consume a ₹10 lakh sum insured, which is why higher covers or top-up/super top-up plans are increasingly recommended for serious illness protection.
Why do health insurance claims get rejected in India? The most common reasons are non-disclosure of pre-existing medical conditions at purchase, claims filed within a policy’s waiting period, treatment at non-network hospitals mistaken for automatic denial, and policy sub-limits (like room rent caps) that weren’t reviewed before buying.
The Bottom Line
The data is unambiguous: India’s out-of-pocket healthcare burden, while improving at the macro level, remains high enough that a single serious diagnosis can undo years of financial planning for the average family. State averages mask enormous individual risk — someone in low-OOPE Bihar can still face a ₹30 lakh cancer treatment bill just as easily as someone in high-OOPE Kerala.
The honest response to “insurance claims sometimes get rejected” isn’t to avoid insurance — it’s to buy it deliberately: disclose your health history accurately, understand your waiting periods before you need them to have expired, size your cover against real treatment costs like the ones above rather than round numbers, and read the sub-limits before, not after, a hospital admission.
The alternative — paying for a bypass surgery, a transplant, or a year of chemotherapy entirely from savings, loans, or asset sales — is the actual risk the data has been describing all along.
